Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety and Efficacy of Pegvisomant in Children With Growth Hormone Excess

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03882034
Recruitment Status : Recruiting
First Posted : March 20, 2019
Last Update Posted : October 23, 2019
Sponsor:
Information provided by (Responsible Party):
National Institutes of Health Clinical Center (CC) ( Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) )